Chiesi Group announces the passing of Honorary President Dr. Paolo Chiesi...

Parma, March 5th, 2024 - Chiesi Group announces the passing of Honorary President Dr. Paolo Chiesi, a fundamental pillar of the company who shaped...

1/32

Chiesi Global Rare Diseases Announces Publication of Results from Phase 3 BALANCE Study in Fabry...

2/32

Chiesi's Sustainability Report 2022: a year of tangible achievements for patients, communities, and...

3/32

ARCHIVE NEWS

Chiesi Group mid-year financial results demonstrate strong growth for 2023

03 August 2023 NEWS

Inclusiveness, transparency and harmony: Chiesi Group introduces Human Rights Policy

31 Juli 2023 NEWS

Chiesi’s 2022 Sustainability Report: “Purpose First”

27 Juli 2023 NEWS

Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc

08 Mai 2023 NEWS

2022 for Chiesi: The Group’s international growth continues

17 April 2023 NEWS

Chiesi Group and Affibody collaborate to develop and commercialize innovative treatments for respiratory diseases

14 März 2023 NEWS

Chiesi appoints Giuseppe Accogli as new Group CEO

01 Februar 2023 NEWS

Chiesi is recertified as a B Corp and sets new tougher objectives for action by 2025

08 November 2022 NEWS

Chiesi receives positive ESG rating from independent rating agency Cerved

30 September 2021 NEWS

Chiesi accelerates path toward full sustainability despite Covid-19 pandemic

23 Juni 2021 NEWS

Chiesi Group roept op tot #ActionOverWords in de strijd tegen klimaatverandering

01 Juni 2021 NEWS

New organisational order for the Chiesi Foundation

03 Mai 2021 NEWS

Chiesi continues cultural transformation with new visual identity that mirrors patients’ language and experiences

22 März 2021 NEWS

Werelddag van de bossen en Chiesi

21 März 2021 NEWS

Chiesi opnieuw erkend als Top Employer

26 Januar 2021 NEWS

Kaia Health and Chiesi Group announce strategic partnership

01 Dezember 2020 NEWS

Zorg Talks 18 november 2020: Wereld COPD-Dag

19 November 2020 NEWS

COPD-patiënt loopt risico bij uitstel van zorg door coronapandemie

17 November 2020 NEWS

Chiesi opnieuw ‘a Great Place to Work’

29 Oktober 2020 NEWS

Chiesi tekent Green Deal Duurzame Zorg

01 Oktober 2020 NEWS

We ACT Day 2020: Chiesi’s global event for a sustainable future return

28 September 2020 NEWS

Moderna and Chiesi Group Establish Collaboration to Discover and Develop mRNA Therapeutics for Pulmonary Arterial Hypertension (PAH)

17 September 2020 NEWS

Chiesi medewerkers over het werken bij Chiesi

15 September 2020 NEWS

"Wie weet is het arrivederci"

01 September 2020 NEWS

Thomas Eichholtz appointed new Head of Global Research and Development at the Chiesi Group

09 Juli 2020 NEWS

Sustained efforts designed to ensure continuity of supply-chain and production despite increased restrictions in Italy and around the world

27 März 2020 NEWS

Geen leverings- en/ of voorraadproblemen verwacht voor Curosurf/ Trimbow, Foster en Atimos ten gevolge van het Covid-19 (Corona) virus

13 März 2020 NEWS

Chiesi Group Announces Establishment of New Global Rare Diseases Division

10 Februar 2020 NEWS

Chiesi Group is the largest pharmaceutical group in the world to be awarded B Corp certification

06 Juni 2019 NEWS

Dit is een website van Chiesi Pharmaceuticals B.V.
Postbus 22517 1100 DA Amsterdam
Tel : +31 (0)88 501 6400
Contact pagina

Approval n°: PM-2023-11832
Laatst gewijzigd op 08/02/2024

CHIESI ON THE WEB